MT-104
/ MabTics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 01, 2025
Efficacy and Safety of MT104, A Dietary Supplement Based on Cuscuta Seeds and Heat-Killed Probiotics, on Cognitive Function in Patients with Mild Cognitive Impairment: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
(PubMed, J Med Food)
- "In addition, no significant findings were identified. This study highlighted the potential of dietary therapeutic strategies focused on reducing the risk of progression from MCI to AD."
Clinical • Journal • Alzheimer's Disease • CNS Disorders • Cognitive Disorders
1 to 1
Of
1
Go to page
1